Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Miller

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Investigative Dermatology|February 5, 2026
CLINICAL BENEFIT OF ADDING RADIATION FOR IMMUNE CHECKPOINT INHIBITOR-REFRACTORY MERKEL CELL CARCINOMA: A 27-PATIENT ANALYSISRian Alam, Ankita A Menon, Peter Y Ch'en, et al.
International Journal of Cardiology|May 31, 2020
Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testingMay Ling Mah, Linda Cripe, Michelle K Slawinski, et al.
Virology Journal|June 23, 2026
Evaluation of a portable multiplex real-time pcr assay for the detection of monkeypox virus and non-variola orthopoxvirusesShanshan Li, Nabojeet Das, Natalie Miller, et al.
Microbial Genomics|December 15, 2021
Genomic comparisons of <i>Escherichia coli</i> ST131 from AustraliaDmitriy Li, Ethan R Wyrsch, Paarthiphan Elankumaran, et al.
Human Gene Therapy|March 7, 2019
Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb InfusionJerry R Mendell, Louis G Chicoine, Samiah A Al-Zaidy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2017
Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional OutcomesJerry R Mendell, Zarife Sahenk, Samiah Al-Zaidy, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Molecular Cancer Therapeutics|November 5, 2021
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug ResistanceKristen Jensen-Pergakes, John Tatlock, Karen A Maegley, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Investigative Dermatology|February 5, 2026
CLINICAL BENEFIT OF ADDING RADIATION FOR IMMUNE CHECKPOINT INHIBITOR-REFRACTORY MERKEL CELL CARCINOMA: A 27-PATIENT ANALYSISRian Alam, Ankita A Menon, Peter Y Ch'en, et al.
International Journal of Cardiology|May 31, 2020
Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testingMay Ling Mah, Linda Cripe, Michelle K Slawinski, et al.
Virology Journal|June 23, 2026
Evaluation of a portable multiplex real-time pcr assay for the detection of monkeypox virus and non-variola orthopoxvirusesShanshan Li, Nabojeet Das, Natalie Miller, et al.
Microbial Genomics|December 15, 2021
Genomic comparisons of <i>Escherichia coli</i> ST131 from AustraliaDmitriy Li, Ethan R Wyrsch, Paarthiphan Elankumaran, et al.
Human Gene Therapy|March 7, 2019
Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb InfusionJerry R Mendell, Louis G Chicoine, Samiah A Al-Zaidy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2017
Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional OutcomesJerry R Mendell, Zarife Sahenk, Samiah Al-Zaidy, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Molecular Cancer Therapeutics|November 5, 2021
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug ResistanceKristen Jensen-Pergakes, John Tatlock, Karen A Maegley, et al.
Pageof 3